TY  - BOOK
TI  - A Study on the Risk Return Evaluation of Pharmaceutical Sector Companies
U1  - WIN/2025/FIN-SPE/PR6728 
PY  - 2025///
CY  - Mumbai
PB  - SFIMAR
KW  - FIN-SPE
KW  - A Study on the Risk Return Evaluation of Pharmaceutical Sector Companies
ER  -